- Home
- / Embla Medical
Embla Medical
Stock Price
KR35.3
2024-10-29
Market Capitalization
KR15.2 B
2024-10-29
Revenue
$928.7 M
FY, 2025
Embla Medical Summary
Company Summary
- Overview
- Embla Medical (formerly known as Ossur) is a company that develops non-invasive orthopedic products. It offers prosthetics and bracing devices for the spinal, hip, knee, foot, ankle, and hands.
- Type
- Public
- Status
- Active
- Founded
- 1971
- HQ
- Reykjavík, IS | view all locations
- Website
- https://emblamedical.com/
- Cybersecurity rating
- ESG rating
- Sectors
Table of Contents
Key People
Margret Lara Friðriksdottir, EVP of People, Strategy & Sustainability
Svafa Grönfeldt, Vice Chairman of the Board of Directors
Alberto Esquenazi, Director
LocationsView all
23 locations detected
Reykjavík, Reykjavíkurborg HQ
Iceland
Grjótháls 5
Dublin, OH
United States
6640 Riverside Dr Suite 360
Irvine, CA
United States
200 Spectrum Center Dr #700
Orlando, FL
United States
9545 S John Young Pkwy #100
North Parramatta, New South Wales
Australia
26 Ross St
Richmond, BC
Canada
6900 Graybar Rd #2150
Embla Medical Financials
Summary Financials
- Revenue (Q1, 2026)
- $232.4M
- Gross profit (Q1, 2026)
- $149.6M
- Net income (Q1, 2026)
- $14.5M
- Cash (Q1, 2026)
- $93.7M
- EBIT (Q1, 2026)
- $24.2M
- Enterprise value
- $15.6B